![]() |


![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of GALNT8 promoter | CTD | PMID:30157460 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of GALNT8 mRNA | CTD | PMID:24449571 | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of GALNT8 promoter | CTD | PMID:23974009 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of GALNT8 intron, Benzo(a)pyrene affects the methylation of GALNT8 promoter | CTD | PMID:30157460 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of GALNT8 promoter | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of GALNT8 mRNA | CTD | PMID:31163220 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of GALNT8 promoter | CTD | PMID:30157460 | |
|
|
|
|
|
|
|
|
1. | GOA_HUMAN data from the GO Consortium |
2. | Pipeline to import KEGG annotations from KEGG into RGD |
3. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
4. | RGD automated import pipeline for gene-chemical interactions |
GALNT8 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Galnt8 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Galnt8 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GALNT8 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GALNT8 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Galnt8 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GALNT8 (Sus scrofa - pig) |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_017417 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
GenBank Nucleotide | AC005833 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AJ271385 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AJ505959 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC140888 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC140889 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471116 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_017417 ⟹ NP_059113 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
TTCCCACAAAAGCTAGGCTGGTTCTGATTCTTAACCTGCTCCAGCAGTGACACACTCAGTCCCAhide sequence |
Protein RefSeqs | NP_059113 | (Get FASTA) | NCBI Sequence Viewer |
GenBank Protein | AAI40889 | (Get FASTA) | NCBI Sequence Viewer |
AAI40890 | (Get FASTA) | NCBI Sequence Viewer | |
CAB89199 | (Get FASTA) | NCBI Sequence Viewer | |
CAD44539 | (Get FASTA) | NCBI Sequence Viewer | |
EAW88835 | (Get FASTA) | NCBI Sequence Viewer | |
Q9NY28 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_059113 ⟸ NM_017417 |
- UniProtKB: | Q9NY28 (UniProtKB/Swiss-Prot) |
- Sequence: |
MMFWRKLPKALFIGLTLAIAVNLLLVFSSKGTLQNLFTGGLHRELPLHLNKRYGAVIKRLSHLEhide sequence |
RGD ID: | 7222823 | |||||||||
Promoter ID: | EPDNEW_H17156 | |||||||||
Type: | initiation region | |||||||||
Name: | GALNT8_2 | |||||||||
Description: | polypeptide N-acetylgalactosaminyltransferase 8 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7222821 | |||||||||
Promoter ID: | EPDNEW_H17157 | |||||||||
Type: | initiation region | |||||||||
Name: | GALNT8_1 | |||||||||
Description: | polypeptide N-acetylgalactosaminyltransferase 8 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 12p13.33-11.22(chr12:121055-28415184)x1 | copy number loss | Global developmental delay [RCV000052776]|See cases [RCV000052776] | Chr12:121055..28415184 [GRCh38] Chr12:282465..28568117 [GRCh37] Chr12:100482..28459384 [NCBI36] Chr12:12p13.33-11.22 |
pathogenic |
GRCh38/hg38 12p13.33-13.32(chr12:2492728-4829842)x1 | copy number loss | Delayed speech and language development [RCV000052777]|See cases [RCV000052777] | Chr12:2492728..4829842 [GRCh38] Chr12:2601894..4939008 [GRCh37] Chr12:2472155..4809269 [NCBI36] Chr12:12p13.33-13.32 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:77187-34380176)x3 | copy number gain | Global developmental delay [RCV000053660]|Coarse facial features [RCV000053661]|See cases [RCV000053660] | Chr12:77187..34380176 [GRCh38] Chr12:282465..34533111 [GRCh37] Chr12:56614..34424378 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-12.1(chr12:80412-25470329)x3 | copy number gain | Corpus callosum agenesis [RCV000053662]|See cases [RCV000053662] | Chr12:80412..25470329 [GRCh38] Chr12:282465..25623263 [GRCh37] Chr12:59839..25514530 [NCBI36] Chr12:12p13.33-12.1 |
pathogenic |
GRCh38/hg38 12p13.33-13.31(chr12:121055-7272606)x3 | copy number gain | Global developmental delay [RCV000053663]|See cases [RCV000053663] | Chr12:121055..7272606 [GRCh38] Chr12:282465..7425202 [GRCh37] Chr12:100482..7316469 [NCBI36] Chr12:12p13.33-13.31 |
pathogenic |
GRCh38/hg38 12p13.33-13.31(chr12:121255-8361746)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053664]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053664]|See cases [RCV000053664] | Chr12:121255..8361746 [GRCh38] Chr12:282465..8514342 [GRCh37] Chr12:100682..8405609 [NCBI36] Chr12:12p13.33-13.31 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:212976-33926913)x4 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053666]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053666]|See cases [RCV000053666] | Chr12:212976..33926913 [GRCh38] Chr12:322142..34079848 [GRCh37] Chr12:192403..33971115 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
NM_017417.1(GALNT8):c.1076G>A (p.Gly359Asp) | single nucleotide variant | Malignant melanoma [RCV000062511] | Chr12:4746161 [GRCh38] Chr12:4855327 [GRCh37] Chr12:4725588 [NCBI36] Chr12:12p13.32 |
not provided |
GRCh38/hg38 12p13.33-13.31(chr12:45740-6945196)x3 | copy number gain | See cases [RCV000135350] | Chr12:45740..6945196 [GRCh38] Chr12:147099..7054359 [GRCh37] Chr12:17360..6924620 [NCBI36] Chr12:12p13.33-13.31 |
pathogenic |
GRCh38/hg38 12p13.33-13.31(chr12:199896-5807366)x1 | copy number loss | See cases [RCV000136848] | Chr12:199896..5807366 [GRCh38] Chr12:309062..5916532 [GRCh37] Chr12:179323..5786793 [NCBI36] Chr12:12p13.33-13.31 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:121255-34603274)x3 | copy number gain | See cases [RCV000136611] | Chr12:121255..34603274 [GRCh38] Chr12:282465..34756209 [GRCh37] Chr12:100682..34647476 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-12.3(chr12:2871741-14987348)x3 | copy number gain | See cases [RCV000137694] | Chr12:2871741..14987348 [GRCh38] Chr12:2980907..15140282 [GRCh37] Chr12:2851168..15031549 [NCBI36] Chr12:12p13.33-12.3 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:121271-34603261)x3 | copy number gain | See cases [RCV000139052] | Chr12:121271..34603261 [GRCh38] Chr12:282465..34756196 [GRCh37] Chr12:100698..34647463 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:54427-34608071)x4 | copy number gain | See cases [RCV000139787] | Chr12:54427..34608071 [GRCh38] Chr12:282465..34761006 [GRCh37] Chr12:33854..34652273 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-q24.33(chr12:121271-133196807)x3 | copy number gain | See cases [RCV000139555] | Chr12:121271..133196807 [GRCh38] Chr12:282465..133773393 [GRCh37] Chr12:100698..132283466 [NCBI36] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh38/hg38 12p13.33-12.2(chr12:1258274-20657577)x3 | copy number gain | See cases [RCV000141905] | Chr12:1258274..20657577 [GRCh38] Chr12:1367440..20810511 [GRCh37] Chr12:1237701..20701778 [NCBI36] Chr12:12p13.33-12.2 |
pathogenic |
GRCh38/hg38 12p13.33-11.1(chr12:64620-34682902)x4 | copy number gain | See cases [RCV000142149] | Chr12:64620..34682902 [GRCh38] Chr12:173786..34835837 [GRCh37] Chr12:44047..34727104 [NCBI36] Chr12:12p13.33-11.1 |
pathogenic |
GRCh38/hg38 12p13.33-13.31(chr12:418421-6235914)x3 | copy number gain | See cases [RCV000143357] | Chr12:418421..6235914 [GRCh38] Chr12:527587..6345080 [GRCh37] Chr12:397848..6215341 [NCBI36] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:148034-34178799)x4 | copy number gain | See cases [RCV000240164] | Chr12:148034..34178799 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
Single allele | copy number gain | See cases [RCV000258805] | Chr12:1..133851895 [GRCh37] | pathogenic|likely pathogenic |
GRCh38/hg38 12p13.32-13.31(chr12:4772521-5854093)x1 | copy number loss | Ductal breast carcinoma [RCV000207062] | Chr12:4772521..5854093 [GRCh38] Chr12:4881687..5963259 [GRCh37] Chr12:12p13.32-13.31 |
uncertain significance |
GRCh37/hg19 12p13.32(chr12:4872405-5347944)x3 | copy number gain | See cases [RCV000239919] | Chr12:4872405..5347944 [GRCh37] Chr12:12p13.32 |
uncertain significance |
GRCh37/hg19 12p13.33-11.1(chr12:89061-34178799)x3 | copy number gain | See cases [RCV000240487] | Chr12:89061..34178799 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-q11(chr12:173786-37869301)x3 | copy number gain | See cases [RCV000449191] | Chr12:173786..37869301 [GRCh37] Chr12:12p13.33-q11 |
pathogenic |
GRCh37/hg19 12p13.33-12.1(chr12:173786-25286865)x3 | copy number gain | See cases [RCV000449287] | Chr12:173786..25286865 [GRCh37] Chr12:12p13.33-12.1 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-6378954)x1 | copy number loss | See cases [RCV000447106] | Chr12:173786..6378954 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x3 | copy number gain | See cases [RCV000447551] | Chr12:173786..34835837 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-5737510)x1 | copy number loss | See cases [RCV000446628] | Chr12:173786..5737510 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-12.2(chr12:173786-20026080)x3 | copy number gain | See cases [RCV000446050] | Chr12:173786..20026080 [GRCh37] Chr12:12p13.33-12.2 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-8257049)x3 | copy number gain | See cases [RCV000446749] | Chr12:173786..8257049 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:189578-34756150) | copy number gain | See cases [RCV000446017] | Chr12:189578..34756150 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-q24.33(chr12:173787-133777902)x3 | copy number gain | See cases [RCV000510482] | Chr12:173787..133777902 [GRCh37] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh37/hg19 12p13.33-q24.33(chr12:173787-133777902) | copy number gain | See cases [RCV000511643] | Chr12:173787..133777902 [GRCh37] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh37/hg19 12p13.33-13.32(chr12:3256714-4980727)x1 | copy number loss | See cases [RCV000511740] | Chr12:3256714..4980727 [GRCh37] Chr12:12p13.33-13.32 |
likely pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:565369-34835837)x3 | copy number gain | See cases [RCV000511580] | Chr12:565369..34835837 [GRCh37] Chr12:12p13.33-11.1 |
likely pathogenic |
GRCh37/hg19 12p13.33-13.2(chr12:173786-11677456)x3 | copy number gain | See cases [RCV000510853] | Chr12:173786..11677456 [GRCh37] Chr12:12p13.33-13.2 |
pathogenic |
GRCh37/hg19 12p13.33-11.22(chr12:173786-28219229)x3 | copy number gain | See cases [RCV000510961] | Chr12:173786..28219229 [GRCh37] Chr12:12p13.33-11.22 |
pathogenic |
GRCh37/hg19 12p13.33-q11(chr12:173786-37869107)x3 | copy number gain | not provided [RCV000683480] | Chr12:173786..37869107 [GRCh37] Chr12:12p13.33-q11 |
pathogenic |
GRCh37/hg19 12p13.32-13.31(chr12:4305058-6066141)x1 | copy number loss | not provided [RCV000683465] | Chr12:4305058..6066141 [GRCh37] Chr12:12p13.32-13.31 |
likely pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x2,3 | copy number gain | not provided [RCV000683478] | Chr12:173786..34835837 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:191242-8122785)x3 | copy number gain | not provided [RCV000683477] | Chr12:191242..8122785 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-5952112)x1 | copy number loss | not provided [RCV000683474] | Chr12:173786..5952112 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-6039841)x1 | copy number loss | not provided [RCV000683475] | Chr12:173786..6039841 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-6201932)x1 | copy number loss | not provided [RCV000683476] | Chr12:173786..6201932 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x3 | copy number gain | not provided [RCV000683479] | Chr12:173786..34835837 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-q24.33(chr12:191619-133777645)x3 | copy number gain | not provided [RCV000750246] | Chr12:191619..133777645 [GRCh37] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh37/hg19 12p13.32(chr12:4768437-4853806)x3 | copy number gain | not provided [RCV000737745] | Chr12:4768437..4853806 [GRCh37] Chr12:12p13.32 |
benign |
GRCh37/hg19 12p13.33-q24.33(chr12:621220-133779118)x3 | copy number gain | not provided [RCV000750253] | Chr12:621220..133779118 [GRCh37] Chr12:12p13.33-q24.33 |
pathogenic |
GRCh37/hg19 12p13.33-11.21(chr12:191619-31733044)x3 | copy number gain | not provided [RCV000750245] | Chr12:191619..31733044 [GRCh37] Chr12:12p13.33-11.21 |
pathogenic |
GRCh37/hg19 12p13.33-12.3(chr12:189216-15001420) | copy number gain | not provided [RCV000767817] | Chr12:189216..15001420 [GRCh37] Chr12:12p13.33-12.3 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:189216-8185497) | copy number gain | not provided [RCV000767819] | Chr12:189216..8185497 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
NC_000012.12:g.(1_3750000)_(5250000_9000000)del | deletion | Tumoral calcinosis, familial, hyperphosphatemic [RCV000758697] | Chr12:3750000..5250000 [GRCh38] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:237588-8278292) | copy number gain | not provided [RCV000767818] | Chr12:237588..8278292 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-8393815)x3 | copy number gain | not provided [RCV000846343] | Chr12:173786..8393815 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
GRCh37/hg19 12p13.32(chr12:4748656-4856696)x3 | copy number gain | not provided [RCV000846458] | Chr12:4748656..4856696 [GRCh37] Chr12:12p13.32 |
uncertain significance |
GRCh37/hg19 12p13.33-11.1(chr12:173786-34496628)x3 | copy number gain | not provided [RCV000847209] | Chr12:173786..34496628 [GRCh37] Chr12:12p13.33-11.1 |
pathogenic |
GRCh37/hg19 12p13.33-13.31(chr12:173786-6346092)x1 | copy number loss | not provided [RCV000847821] | Chr12:173786..6346092 [GRCh37] Chr12:12p13.33-13.31 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:4130 | AgrOrtholog |
COSMIC | GALNT8 | COSMIC |
Ensembl Genes | ENSG00000130035 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000252318 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000440383 | UniProtKB/TrEMBL | |
ENSP00000444876 | UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000252318 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000535354 | UniProtKB/TrEMBL | |
ENST00000542998 | UniProtKB/TrEMBL | |
Gene3D-CATH | 3.90.550.10 | UniProtKB/Swiss-Prot |
GTEx | ENSG00000130035 | GTEx |
HGNC ID | HGNC:4130 | ENTREZGENE |
Human Proteome Map | GALNT8 | Human Proteome Map |
InterPro | Glyco_trans_2-like | UniProtKB/Swiss-Prot |
Nucleotide-diphossugar_trans | UniProtKB/Swiss-Prot | |
Ricin_B-like_lectins | UniProtKB/Swiss-Prot | |
Ricin_B_lectin | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:26290 | UniProtKB/Swiss-Prot |
NCBI Gene | 26290 | ENTREZGENE |
OMIM | 606250 | OMIM |
Pfam | Glycos_transf_2 | UniProtKB/Swiss-Prot |
Ricin_B_lectin | UniProtKB/Swiss-Prot | |
PharmGKB | PA28543 | PharmGKB |
PROSITE | RICIN_B_LECTIN | UniProtKB/Swiss-Prot |
SMART | RICIN | UniProtKB/Swiss-Prot |
Superfamily-SCOP | SSF50370 | UniProtKB/Swiss-Prot |
SSF53448 | UniProtKB/Swiss-Prot | |
UniGene | Hs.511985 | ENTREZGENE |
UniProt | GALT8_HUMAN | UniProtKB/Swiss-Prot |
H0YFU9_HUMAN | UniProtKB/TrEMBL | |
H0YGU9_HUMAN | UniProtKB/TrEMBL | |
Q68VJ3_HUMAN | UniProtKB/TrEMBL | |
Q9NY28 | ENTREZGENE | |
UniProt Secondary | B2RU02 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2014-03-19 | GALNT8 | polypeptide N-acetylgalactosaminyltransferase 8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) | Symbol and/or name change | 5135510 | APPROVED | |
2011-09-01 | GALNT8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) | GALNT8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on GALNT8 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1350587 |
Created: | 2005-03-08 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.